Saved Bookmarks
| 1. |
Which of the following is an NSAID for Alzheimer’s disease, that lead to Phase III clinical trials?(a) Bapineuzumab(b) Alzhemed(c) Flurizan(d) Doxil |
|
Answer» The correct answer is (c) Flurizan Explanation: Flurizan was the non-steroidal anti-inflammatory drug or NSAID for treating Alzheimer’s which reached the stage of phase III clinical trials but could proceed thereafter. |
|